One Case of Reversible Posterior Leukoencephalopathy Syndrome Induced by Methotrexate

Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (2): 126-128.

One Case of Reversible Posterior Leukoencephalopathy Syndrome Induced by Methotrexate

TIAN Jixin, ZHANG Ping, MIAO Wenjuan, LIAO Yingxi, WANG Xiaodan, LI Shan, YAN Haihong^*

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China

Received:2019-03-12 Revised:2019-03-12 Online:2019-02-25 Published:2019-03-12
Contact: *严海泓,女,本科,副主任药师,临床药学。E-mail：tianjixin@ihcams.ac.cn

Abstract

CLC Number:

R994.11

TIAN Jixin, ZHANG Ping, MIAO Wenjuan, LIAO Yingxi, WANG Xiaodan, LI Shan, YAN Haihong. One Case of Reversible Posterior Leukoencephalopathy Syndrome Induced by Methotrexate[J]. Chinese Journal of Pharmacovigilance, 2019, 16(2): 126-128.

References

[1] Dufourg M N, Landman-Parker J, Auclerc M F, et a1. Age and high-dose methotrexate are associated to clinical acute encepha-lopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children[J]. Leukemia, 2007, 21(2): 238-247.
[2] 罗学群, 柯志勇, 刘栓梁. 大剂量化疗药致脑毒性三例[J]. 中华血液学杂志, 2004, 25(2): 128.
[3] 徐基昕, 孔令军, 张淑红,等. 甲氨蝶呤治疗儿童急性淋巴细胞白血病致白质脑病二例[J]. 白血病·淋巴瘤, 2016, 25(10): 623-625.
[4] Donmez F Y, Guleryuz P, Agildere M.MRI findings in childhood PRES: What is different than the Adults?[J]. Clin Neuroradiol, 2016, 26(2): 209-213.
[5] Bhojwani D, Sabin N D, Pei D, et a1. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphobla-stic leukemia[J]. J Clin Oncol, 2014, 32(9): 949-959.
[6] Kishi S, Cheng C, French D, et a1. Ancestry and pharmacogenetics of antileukemic drug toxicity[J]. Blood, 2007, 109(10): 4151-4157.
[7] Marra A, Vargas M, Striano P, et a1. Posterior reversible encephalo-pathy syndrome: the endothelial hypotheses[J]. Med Hypotheses, 2014, 82(5): 619-622.
[8] Gümüs H, Per H, Kumandas S, et a1. Reversible posterior leukoen-cephalopathy syndrome in childhood: report of nine cases and review of the literature[J]. Neurol Sci, 2010, 31(2): 125-131.
[9] González-Suárez I, Aguilar-Amat MJ, Trigueros M, et a1. Leukoencephalopathy due to oral methotrexate[J]. Cerebellum, 2014, 13(1): 178-183.
[10] 尤海生, 董亚琳. 甲氨蝶呤鞘内注射致神经系统不良反应分析[J]. 中国医院药学杂志, 2008, 28(16): 1386-1388.
[11] Vezmar S, Becker A, Bode U, et a1. Biochemical and clinical aspects of methotrexate neurotoxicity[J]. Chemotherapy, 2003, 49(1-2): 92-104.
[12] Becker A, Vezmar S, Linnebank M, et a1. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate[J]. Int J Clin Pharmacol Ther, 2007, 45(9): 504-515.
[13] Vagace J M, Caceres-Marzal C, Jimenez M, et a1. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis[J]. Am J Hematol, 2011, 86(1): 98-101.

[1]	SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131.
[2]	ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136.
[3]	BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
[4]	JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
[5]	LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
[6]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[7]	ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
[8]	WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194.
[9]	LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
[10]	XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
[11]	GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207.
[12]	FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210.
[13]	LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
[14]	CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
[15]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.